Chemclin Diagnostics Co. Ltd. A (688468) — Free Cash Flow Generation Index

Latest as of September 2025: 0.73x

Chemclin Diagnostics Co. Ltd. A (688468) has a Free Cash Flow Generation Index of 0.73x as of September 2025. Free cash flow of CN¥25.24 Million represents 1% of operating cash flow (CN¥34.41 Million). See working capital position of Chemclin Diagnostics Co. Ltd. A to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

0.73x
Free Cash Flow / Operating CF

Free Cash Flow

CN¥25.24 Million
CNY

Operating Cash Flow

CN¥34.41 Million
CNY

Capital Expenditures

CN¥9.16 Million
CNY

Chemclin Diagnostics Co. Ltd. A Free Cash Flow Generation Index (2017–2025)

Historical FCF Generation Index trend for Chemclin Diagnostics Co. Ltd. A across 9 annual periods. Explore Chemclin Diagnostics Co. Ltd. A cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Chemclin Diagnostics Co. Ltd. A (2017–2025)

Year-by-year Free Cash Flow Generation Index for Chemclin Diagnostics Co. Ltd. A. For the full company profile including market capitalisation, see 688468 company net worth.

Year FCG Index Free Cash Flow (CNY) Operating CF Capital Expenditures YoY Change
2025 0.26x CN¥24.01 Million CN¥93.90 Million CN¥69.88 Million ▼ -29.0%
2024 0.36x CN¥60.46 Million CN¥167.95 Million CN¥107.49 Million ▲ +148.5%
2023 -0.74x CN¥-128.32 Million CN¥173.05 Million CN¥301.37 Million ▼ -252.0%
2022 0.49x CN¥119.28 Million CN¥244.56 Million CN¥125.28 Million ▼ -20.8%
2021 0.62x CN¥116.31 Million CN¥188.86 Million CN¥72.55 Million ▲ +36.3%
2020 0.45x CN¥68.65 Million CN¥151.95 Million CN¥83.31 Million ▼ -37.7%
2019 0.73x CN¥146.03 Million CN¥201.27 Million CN¥55.24 Million ▲ +8.0%
2018 0.67x CN¥99.17 Million CN¥147.68 Million CN¥48.51 Million ▲ +21.1%
2017 0.55x CN¥74.03 Million CN¥133.46 Million CN¥59.43 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).